Interobserver reproducibility in the interpretation of captopril renograms from patients suspected of having renovascular hypertension

Clinical Nuclear Medicine

Volumn 29, Issue 8, 2004, Pages 479-484

  Tondeur, Marianne ^a   Sand, Alain ^b   Ham, Hamphrey ^c  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b City Hospital De Bijloke   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Captopril; Interobserver; Interpretation; Renogram; Reproducibility

Indexed keywords

CAPTOPRIL; MERTIATIDE TC 99M;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC TEST; HUMAN; HYPOTENSION; INTERNET; RENOGRAPHY; RENOVASCULAR HYPERTENSION; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY; OBSERVER VARIATION; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M MERTIATIDE;

EID: 3242795822     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000132882.78831.ec     Document Type: Article

References (20)

1. Taylor AT, Fletcher JW, Nally JV, et al. Society of Nuclear Medicine Procedure Guideline for Diagnosis of Renovascular Hypertension 2.0. Society of Nuclear Medicine Procedure Guidelines Manual; 2001-2002:82-86.
2. Nally JV, Black HR. State of the art review: captopril renography-pathophysiological considerations and clinical observations. Semin Nucl Med. 1992;22:85.
3. Barron JB, Lamki LM, Kim EE. Genitourinary nuclear medicine II. In: Mitchell W, ed. Diagnostic Nuclear Medicine. Baltimore: Williams & Wilkins; 1996:1191-1209.
4. Prigent A. The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues. Eur J Nucl Med. 1993;20:625.
5. Ramirez G, Savader S, Farber S, et al. Low-dose captopril scintigraphy in the evaluation of renovascular hypertension. Clin Nucl Med. 1990;15:480.
6. Fanti S, Dondi M, Barozzi L, et al. Detection of renal artery stenosisby means of captopril renal scintigraphy in patients with multiple renal arteries. Clin Nucl Med. 1992;11:849.
7. Mousa D, Hamilton D, Hassan A, et al. The diagnosis of segmental transplant renal artery stenosis by captopril renography. Clin Nucl Med. 1999;24:504.
8. Oei HY. Captopril renography: early observations and diagnostic criteria. Am J Hypertens. 1991;4:678S.
9. Nally JV, Chen C, Fine E, et al. Diagnostic criteria of renovascular hypertension with captopril renography: a consensus statement. Am J Hypertens. 1991;4:749S.
10. Nally JV, Barton DP. Contemporary approach to diagnosis and evaluation of renovascular hypertension. Urol Clin North Am. 2001;28:781.
11. Ramsay D, Belton I, Finlay D. A review of captopril renal scintigraphy and its effect on patient management. Nucl Med Commun. 1997;18:631.
12. Dubovsky EV, Russell CD, Japanwalla M, et al. Bilateral response to captopril is non specific. Eur J Nucl Med. 1991;18:575.
13. Balink H, Mertens IJ, Stevens H, et al. Captopril renography and the relevance of abnormal but bilateral identical curves in the diagnosis of renal artery stenosis. Nucl Med Commun. 2001;22:971.
14. Roccatello D, Piciotto G. Captopril-enhanced scintigraphy using the method of the expected renogram: improved detection of patients with renin-dependent hypertension due to functionally significant renal artery stenosis. Nephrol Dial Transplant. 1997;10:2081.
15. Levey CS, Schraml FV, Abreu SH, et al. False-positive result of a captopril-enhanced radionuclide renogram in a child secondary to dehydration. Clin Nucl Med. 1999;24:6.
16. Claveau-Tremblay R, Turpin S, De Braekeleer M, et al. False positive captopril renography in patients taking calcium antagonists. J Nucl Med. 1998;9:1621.
17. Ludwig V, Martin WH, Delbeke D. Calcium channel blockers: a potential cause of false-positive captopril renography. Clin Nucl Med. 2003;28:108.
18. Balingit AG, Anderson JH. Clinical application of captopril renal scintigraphy in Takayasu's arteritis. Clin Nucl Med. 1993;18:742.
19. Krijnen P, Oei HY, Claessens RA, et al. Interobserver agreement on captopril renography for assessing renal vascular disease. J Nucl Med. 2002;43:330.
20. Schreij G, van Kroonenburgh MJ, Heidendal GK, et al. Interpretation of captopril renography by nuclear medicine physicians. J Nucl Med. 1995;36:2192.